Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Vimseltinib 与安慰剂治疗腱鞘巨细胞瘤 (MOTION):一项多中心、随机、双盲、安慰剂对照的 3 期试验
期刊:Lancet
影响因子:88.5
doi:10.1016/S0140-6736(24)00885-7
Gelderblom, Hans; Bhadri, Vivek; Stacchiotti, Silvia; Bauer, Sebastian; Wagner, Andrew J; van de Sande, Michiel; Bernthal, Nicholas M; López Pousa, Antonio; Razak, Albiruni Abdul; Italiano, Antoine; Ahmed, Mahbubl; Le Cesne, Axel; Tinoco, Gabriel; Boye, Kjetil; Martín-Broto, Javier; Palmerini, Emanuela; Tafuto, Salvatore; Pratap, Sarah; Powers, Benjamin C; Reichardt, Peter; Casado Herráez, Antonio; Rutkowski, Piotr; Tait, Christopher; Zarins, Fiona; Harrow, Brooke; Sharma, Maitreyi G; Ruiz-Soto, Rodrigo; Sherman, Matthew L; Blay, Jean-Yves; Tap, William D